Clinical experiences using radium-223, a novel α-emitting bone-seeking radiopharmaceutical, in breast and prostate cancer patients with skeletal metastases

被引：0
|
作者：
Nilsson, S
Larsen, RH
Bruland, OS
机构：
[1] Norwegian Radium Hosp, Oslo, Norway
[2] Algeta ASA, Oslo, Norway
[3] Karolinska Hosp, S-10401 Stockholm, Sweden
来源：
CANCER TREATMENT REVIEWS | 2005年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
51
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [1] RADIUM REVISITED: CLINICAL EXPERIENCES WITH A NOVEL ALPHA-EMITTING BONE-SEEKING RADIOPHARMACEUTICAL IN PATIENTS WITH SKELETAL METASTASES FROM PROSTATE AND BREAST CANCER
    Nilsson, S.
    Larsen, R. H.
    Bruland, O. S.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3445 - 3446
  • [2] Alpha particle-emitting radium-223: A promising bone-seeking radiopharmaceutical product for the treatment of skeletal metastases
    Bruland, OS
    Nilsson, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 (09) : 1587 - 1587
  • [3] Bone-seeking radiopharmaceuticals in patients with skeletal metastases. Clinical experience using alpha-emitting radium-223
    Nilsson, S.
    Larsen, R. H.
    Bruland, O. S.
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S23 - S24
  • [4] Radium-223 Therapy of Bone Metastases in Prostate Cancer
    Nilsson, Sten
    SEMINARS IN NUCLEAR MEDICINE, 2016, 46 (06) : 544 - 556
  • [5] Phase I clinical trial exploring the alpha emitting radium-223 against skeletal metastases: blood clearance in patients with breast and prostate cancer
    Larsen, RH
    Borch, KW
    Aas, M
    Fossaa, SD
    Balteskard, L
    Traasdahl, E
    Hess, S
    Salberg, G
    Henriksen, G
    Schoultz, BW
    Nilsson, S
    Bruland, OS
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 285 - 285
  • [6] First clinical experience with α-emitting radium-223 in the treatment of skeletal metastases
    Nilsson, S
    Larsen, RH
    Fosså, SD
    Balteskard, L
    Borch, KW
    Westlin, JE
    Salberg, G
    Bruland, OS
    CLINICAL CANCER RESEARCH, 2005, 11 (12) : 4451 - 4459
  • [7] Measurement and radiation control of α-emitting radium-223 in radionuclide therapy for prostate cancer with bone metastases
    Hosono, Makoto
    Hohara, Sin-ya
    Yamanishi, Hirokuni
    Inagaki, Masayo
    Wakabayashi, Genichiro
    Sakaguchi, Kenta
    Hanaoka, Kohei
    Itoh, Tetsuo
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [8] Utilization of Radium-223 in Metastatic Prostate Cancer Patients and Novel Prognostic Indicators In Radium-223 Patients
    Parsons, M. W.
    Tward, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E899 - E899
  • [9] First Danish experiences of Radium-223 treatment to patients with prostate cancer and bone metastases. Is it safe for the staff?
    Cortsen, A. K.
    Cortsen, A. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S857 - S857
  • [10] Radium-223 Chloride: Extending Life in Prostate Cancer Patients by Treating Bone Metastases
    Wissing, Michel D.
    van Leeuwen, Fijs W. B.
    van der Pluijm, Gabri
    Gelderblom, Hans
    CLINICAL CANCER RESEARCH, 2013, 19 (21) : 5822 - 5827
12345